AB0380 Treat-to-target in systemic lupus erythematosus: report from the t2t/sle working party

RF Van Vollenhoven, M Mosca, G Bertsias… - Annals of the …, 2013 - ard.bmj.com
Background The principle of “treating-to-target” has been applied successfully to many
diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying …

02 Challenges in the development of a universal SLE patient charter

E Bonfá - 2023 - lupus.bmj.com
Despite advances in understanding and managing systemic lupus erythematosus (SLE),
patients continue to face significant challenges in receiving optimal care and support. The …

POS0306-PARE GROWING LUPUS EUROPE BASED ON A STRATEGIC PLAN–WORTH THE EFFORT, AND EASIER TO DUPLICATE THAN YOU THINK

A Cornet, F Marchiori, CK Yiasoumi, ID Povilaite… - 2024 - ard.bmj.com
Background: In the absence of strategic direction, patient groups struggle to deliver results
that meet their ambitions. Projects selection based on short term considerations or …

Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide

M Mosca, IN Bruce, J Andersen, MF Ugarte-Gil… - …, 2024 - academic.oup.com
SLE presents significant challenges for patients and health-care professionals (HCPs), both
across Europe and worldwide. Improving health-care outcomes for patients with SLE …

POS0152 PREVALENCE AND OUTCOMES OF SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): OBSERVATIONS FROM A MULTINATIONAL …

R Kandane-Rathnayake, W Louthrenoo, CS Lau… - 2024 - ard.bmj.com
Background: A subset of patients with systemic lupus erythematosus (SLE) suffer serious
manifestations and are relatively resistant to conventional treatments, such as combinations …

Recommendations for systemic lupus erythematosus: balancing evidence and eminence to facilitate the medical care of a complex disease

G Bertsias - Rheumatic Disease Clinics, 2022 - rheumatic.theclinics.com
Owing to its systemic nature with multiple organs potentially being affected concurrently or
sequentially and at varying degrees of severity, the management of systemic lupus …

Guidelines for the management of systemic lupus erythematosus: great synthesis of evidence and eminence with limited focus on patient's needs

M Schneider - Rheumatology, 2018 - academic.oup.com
Progress in medicine is mostly based on evidence from international collaborations and
trials, which are especially needed in infrequent diseases, such as SLE. In addition to …

AB1553-HPR BASELINE CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES–THE LUPUSNET FEDERATED DATA NETWORK

U Sbarigia, F Zazzetti, M Lewi, M Van Speybroeck… - 2024 - ard.bmj.com
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with a broad
range of clinical manifestations and a high unmet need across patient populations. Real …

AB0485 TRIGGERS OF DISEASE FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS

S Skhiri, AB Chatti, S Toujani, Z Meddeb, C Abdelkefi… - 2022 - ard.bmj.com
Background Systemic lupus erythematosus (SLE) is a chronic relapsing-remitting disease
characterized by a clinical heterogeneity, an unpredictable pattern and a capricious course …

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

A Fanouriakis, M Kostopoulou, J Andersen… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the management of systemic lupus
erythematosus (SLE) based on emerging new evidence. Methods An international Task …